Sentiment-Signal
6,9
Stark Bearisch
Composite Score (0–100)
Insider (25%)
0
Keine Insider-Käufe
Institutionell (22,5%)
0
Keine neuen Positionen
Aktivist (12,5%)
0
Kein 13D/13G
Risikofreier Zins (T-Bills): 3,70% (Stand: 31.03.2026)
Score-Verlauf (90 Tage)
Stammdaten
Greenwich LifeSciences, Inc., a clinical stage biopharmaceutical company, focuses on the development of novel cancer immunotherapies for breast cancer and other HER2/neu-expressing cancers. Its lead product candidate is the GP2, an immunotherapy, which has completed Phase IIb clinical trial to prevent breast cancer recurrences in patients who have previously undergone surgery. The company was formerly known as Norwell, Inc. and changed its name to Greenwich LifeSciences, Inc. in March 2018. Greenwich LifeSciences, Inc. was incorporated in 2006 and is headquartered in Stafford, Texas.
Unternehmen & Branche
| Name | Greenwich LifeSciences, Inc. |
|---|---|
| Ticker | GLSI |
| CIK | 0001799788 |
| Boerse | US |
| Sektor | Healthcare |
| Industrie | Biotechnology |
| SIC | 2834 · Pharmaceutical Preparations |
Wertpapier & Kennzahlen
| CUSIP | – |
|---|---|
| ISIN | – |
| Typ | Common Stock |
| Marktkapitalisierung | 298,4 Mio. USD |
| Beta | 1,53 |
| Dividendenrendite | 0,00 % |
Externe Quellen: SEC EDGAR » · FMP-Profil » · Yahoo Finance »
Finanzkennzahlen (SEC XBRL)
| Periode | Filing | Umsatz | Nettoergebnis | EPS | Aktiva | Eigenkapital |
|---|---|---|---|---|---|---|
| 2025-09-30 | 10-Q | -4,151,845 | -0.30 | 3,806,978 | 2,184,977 | |
| 2025-06-30 | 10-Q | -4,025,278 | -0.30 | 3,125,101 | 1,439,492 | |
| 2025-03-31 | 10-Q | -3,258,362 | -0.25 | 2,750,835 | 1,312,311 | |
| 2024-12-31 | 10-K | -15,788,809 | -1.21 | 4,093,769 | 2,534,036 | |
| 2024-09-30 | 10-Q | -2,668,713 | -0.20 | 5,825,049 | 4,982,665 | |
| 2024-06-30 | 10-Q | -2,606,682 | -0.20 | 7,228,460 | 5,875,432 | |
| 2024-03-31 | 10-Q | -2,473,195 | -0.19 | 5,510,463 | 5,120,852 | |
| 2023-12-31 | 10-K | -8,891,803 | -0.69 | 6,994,815 | 6,700,409 | |
| 2023-09-30 | 10-Q | -2,391,789 | -0.19 | 9,149,913 | 8,852,626 | |
| 2023-06-30 | 10-Q | -1,628,373 | -0.13 | 10,951,439 | 10,649,893 | |
| 2023-03-31 | 10-Q | -2,124,902 | -0.17 | 11,919,319 | 11,683,744 | |
| 2022-12-31 | 10-K | -7,825,237 | -0.61 | 13,477,029 | 13,214,124 | |
| 2022-09-30 | 10-Q | -2,319,024 | -0.18 | 15,647,993 | 15,410,114 | |
| 2022-06-30 | 10-Q | -746,073 | -0.06 | 17,198,699 | 16,969,565 | |
| 2022-03-31 | 10-Q | -1,969,628 | 19,754,808 | 19,513,640 | ||
| 2021-12-31 | 10-K | -4,570,576 | 27,216,884 | 26,831,712 | ||
| 2021-09-30 | 10-Q | -863,118 | 28,919,511 | 28,464,392 | ||
| 2021-06-30 | 10-Q | -749,745 | 29,815,053 | 29,162,459 | ||
| 2021-03-31 | 10-Q | -597,008 | 30,420,275 | 29,747,153 | ||
| 2020-12-31 | 10-K | -1,862,962 | 28,676,602 | 27,631,110 |
Fondsaktivität (Vorquartalsvergleich)
Keine Fondsdaten für dieses Unternehmen vorhanden.
Insider-Transaktionen (12 Monate)
Keine Insider-Käufe/Verkäufe in den letzten 12 Monaten.
Top-Fondshalter
Keine Fondsdaten zu dieser Aktie vorhanden.